✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals

Dhanvantri Jeevan Rekha Ltd.

ZDHJERK

Market Cap
₹8 Cr.
P/E
15.05

Dhanvantri Jeevan Rekha Ltd.

  • DhanvantriJeevan Rek
  • Clinitech Laboratory
  • Dr Lalchandani Labs
FAQs on Dhanvantri Jeevan Rekha Ltd. Shareprice

DhanvantriJeevan Rek has given better returns compared to its competitors.
DhanvantriJeevan Rek has grown at ~26.82% over the last 5yrs while peers have grown at a median rate of 17.6%

Yes, DhanvantriJeevan Rek is expensive.
Latest PE of DhanvantriJeevan Rek is 15.05, while 3 year average PE is 10.61.
Also latest EV/EBITDA of DhanvantriJeevan Rek is 7.58 while 3yr average is 5.84.

View FAQ's On Business
Growth Table
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Balance Sheet
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Cash Flow
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Quarterly Results
  • Dhanvantri Jeevan Rekha Ltd.
  • Clinitech Laboratory
  • Dr Lalchandani Labs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Dhanvantri Jeevan Rekha Ltd. Financials

Balance sheet of DhanvantriJeevan Rek is moderately strong.

Yes, The net debt of DhanvantriJeevan Rek is increasing.
Latest net debt of DhanvantriJeevan Rek is -₹2.54 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹5.9 Crs.

Yes, profit is increasing.
The profit of DhanvantriJeevan Rek is ₹0.51 Crs for TTM, ₹0.17 Crs for Mar 2024 and -₹0.22 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
DhanvantriJeevan Rek latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech